Question

in both sterile & non-sterile compounding, the ____ must report confirmed incidents of *product contamination* to the NJ BOP within ____ hrs

Answer 1

The pharmacist-in-charge must report confirmed product contamination to the New Jersey Board of Pharmacy within a specific timeframe, similar to how the FDA requires reporting of serious adverse drug events within 15 days.

Step-by-step explanation:

In the context of pharmacy practice, particularly in New Jersey, the pharmacist-in-charge must report confirmed incidents of product contamination to the New Jersey Board of Pharmacy (NJ BOP) within a specified timeframe. While the specific reporting time is not provided in the question, in the case of adverse drug events, the FDA requires sponsors to report serious and fatal adverse drug events within 15 days. This requirement ensures that any potential threats to patient safety due to product contamination are addressed promptly and effectively, allowing for corrective measures to be taken to prevent further incidents.